Atsena Therapeutics Receives FDA Clearance of an Investigational Gene Therapy for X-Linked Retinoschisis
The U.S. Food and Drug Administration (FDA) has cleared Atsena Therapeutics’ Investigational New Drug (IND) application for a Phase I/II clinical trial of ATSN-201 in patients with X-linked retinoschisis (XLRS). Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.
Roozbeh Tabrizian Named Nelms Rising Star Professor
The Warren B. Nelms Institute for the Connected World has named a new Nelms Rising Star Professor, UF engineering professor Roozbeh Tabrizian, Ph.D. This endowment was made possible thanks to a generous donation by David Nelms and the Nelms family.
UF Health Cancer Center Awards American Cancer Society Pilot Grants
The University of Florida Health Cancer Center has awarded the 2023 American Cancer Society Institutional Research Grant Pilot Projects, as part of its efforts to support early-stage investigators in cancer-related research studies. These projects, which are supported by Grant #21-139-01-IRG from the American Cancer Society, aim to address one of six research priorities: etiology, obesity/healthy eating and active living, screening and diagnosis, treatment, survivorship, and health equity across the cancer continuum.
UF Researchers Receive NCI Grant to Study microRNA Degradation in Acute Lymphoblastic Leukemia
A team of University of Florida researchers has received a five-year $2.5 million grant from the National Cancer Institute to study gene regulation in acute lymphoblastic leukemia (ALL).
Breakthrough Polymer Research Promises to Revolutionize Recycling
UF-led research makes major leap toward greener future.
Sparian Biosciences Awarded $19 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-518 for Stimulant Use Disorder Through Phase 1 Clinical Development
Sparian Biosciences, Inc., a clinical-stage CNS-focused biopharmaceutical company, announced it has been awarded a $19 million, five-year grant to fund the development of SBS-518 from IND submission through Phase 1 clinical development.
Confronting Aids in Florida With Artificial Intelligence
A University of Florida research team is playing its part to stop the global HIV epidemic, applying the power of artificial intelligence to medical records to uncover patterns of risk and bias that have left some patients in Florida with poor access to today’s effective treatments — so effective that HIV infections are not sexually transmitted.
Study Uncovers Gut Bacteria Differences in Children Who Later Develop Juvenile Idiopathic Arthritis
For the first time, scientists have shown that gut bacteria differences are associated with later development of juvenile idiopathic arthritis, a debilitating rheumatic childhood disease, and that these differences are present years before the disease is diagnosed.
UF/IFAS Researchers To Train Workforce Preventing Mosquito-Borne Disease Transmission
Three faculty members at the UF/IFAS Florida Medical Entomology Laboratory (FMEL) recently received $8.5 million from the Center for Disease Control (CDC) to manage mosquito-borne disease transmission. Increasingly prevalent diseases in the Southeast include West Nile fever and Zika, among others. New diseases are also likely to emerge in the future.
University of Florida and Synhelion To Scale Up Solar Hydrogen Energy Solution
Synhelion and its partner, University of Florida, announced today that their joint project has been awarded US$ 2.7 million from the U.S. Department of Energy Solar Energy Technologies Office (SETO). The project aims to accelerate the large-scale development and deployment of concentrating solar thermal power (CSP) technology to produce green hydrogen for industrial decarbonization and electric power generation and storage.